Skip to main content

Main menu

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Other Publications
    • cbm

User menu

  • My alerts

Search

  • Advanced search
Cancer Biology & Medicine
  • Other Publications
    • cbm
  • My alerts
Cancer Biology & Medicine

Advanced Search

 

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Follow cbm on Twitter
  • Visit cbm on Facebook

cell proliferation

  • You have access
    Targeting the COP9 signalosome for cancer therapy
    Wenqi Du, Ruicheng Zhang, Bilal Muhammad and Dongsheng Pei
    Cancer Biology & Medicine May 2022, 19 (5) 573-590; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0605
  • You have access
    The cancer-testis gene, MEIOB, sensitizes triple-negative breast cancer to PARP1 inhibitors by inducing homologous recombination deficiency
    Yayun Gu, Cheng Wang, Rongxuan Zhu, Jianshui Yang, Wenwen Yuan, Yanhui Zhu, Yan Zhou, Na Qin, Hongbing Shen, Hongxia Ma, Hongxia Wang, Xiaoan Liu and Zhibin Hu
    Cancer Biology & Medicine February 2021, 18 (1) 74-87; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0071
  • You have access
    Effects of HMGB1 Expression Suppressed by siRNA on Cell Cycle and Proliferation of Human Cervical Cancer Cell Line HeLa
    Yuan-yuan QIU, Hui-yu WANG and Quan HAO
    Clinical Oncology and Cancer Research April 2010, 7 (2) 128-133; DOI: https://doi.org/10.1007/s11805-010-0507-y
  • You have access
    Study on Inhibition of Growth of ACHN Cells via shRNA Expression Vector-Mediated Cycline1 Gene Silencing
    Jiang Wang, Anmin Chen and Fengjin Guo
    Clinical Oncology and Cancer Research February 2009, 6 (1) 29-35; DOI: https://doi.org/10.1007/s11805-009-0029-7
  • You have access
    Suppression of Glioma-Cell Survival by Antisense and Dominant-Negative AKT2 RNA
    Peiyu Pu, Chunsheng Kang, Jie Li and Guangxiu Wang
    Chinese Journal of Clinical Oncology June 2005, 2 (3) 609-614;

Navigate

  • Home
  • Current Issue

More Information

  • About CBM
  • About CACA
  • About TMUCIH
  • Editorial Board
  • Subscription

For Authors

  • Instructions for authors
  • Journal Policies
  • Submit a Manuscript

Journal Services

  • Email Alerts
  • Facebook
  • RSS Feeds
  • Twitter

 

© 2026 Cancer Biology & Medicine

Powered by HighWire